Literature DB >> 11402881

Fibroblasts genetically modified to produce BDNF support regrowth of chronically injured serotonergic axons.

Y Jin1, A Tessler, I Fischer, J D Houle.   

Abstract

Cells genetically modified to release a variety of growth and/or neurotrophic factors have been used for transplantation into the injured spinal cord as a means to deliver therapeutic products. Axon growth into and through such transplants has been demonstrated after intervention after an acute injury. The present study examined their potential to support regeneration in a chronic injury condition. Five weeks after a cervical hemisection in adult rats, the lesion site was debrided of scar tissue and expanded in both rostral and caudal directions. Animals received a transplant of cultured normal fibroblasts (control) or fibroblasts genetically modified to produce brain-derived neurotrophic factor (BDNF). Six weeks later, animals were killed to determine the extent of growth of serotonergic axons into the transplant. Axons immunoreactive for serotonin (5-HT-ir) were found to cross the rostral interface of host spinal cord readily with either type of fibroblast cell transplant, but the number and density of 5-HT-ir axons extending into the BDNF-producing transplants was markedly greater than those in the control fibroblasts. Axons coursed in all directions among normal fibroblast transplants, whereas growth was more oriented along a longitudinal plane when BDNF was being released by the transplanted cells. The length of growth and the percentage of the transplant length occupied by 5-HT-ir axons were significantly greater in BDNF-producing transplants than in the normal fibroblasts. Many serotonergic axons approached the caudal end of the BDNF-producing cell transplants, although most failed to penetrate the host spinal cord distal to the lesion. These results indicate that whereas fibroblast cell transplants alone can support regrowth of axons from chronically injured supraspinal neurons, modification of these cells to produce BDNF results in a significant increase in the extent of growth into the transplant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11402881     DOI: 10.1177/154596830001400407

Source DB:  PubMed          Journal:  Neurorehabil Neural Repair        ISSN: 1545-9683            Impact factor:   3.919


  17 in total

Review 1.  Gene therapy approaches to enhancing plasticity and regeneration after spinal cord injury.

Authors:  Steffen Franz; Norbert Weidner; Armin Blesch
Journal:  Exp Neurol       Date:  2011-01-31       Impact factor: 5.330

2.  Transduced Schwann cells promote axon growth and myelination after spinal cord injury.

Authors:  Kevin L Golden; Damien D Pearse; Bas Blits; Maneesh S Garg; Martin Oudega; Patrick M Wood; Mary Bartlett Bunge
Journal:  Exp Neurol       Date:  2007-07-13       Impact factor: 5.330

3.  Axonal regeneration of different tracts following transplants of human glial restricted progenitors into the injured spinal cord in rats.

Authors:  Ying Jin; Jed S Shumsky; Itzhak Fischer
Journal:  Brain Res       Date:  2018-02-01       Impact factor: 3.252

4.  Effects of bioengineered scaffold loaded with neurotrophins and locomotor training in restoring H-reflex responses after spinal cord injury.

Authors:  Babitha Tom; Jaclyn Witko; Michel Lemay; Anita Singh
Journal:  Exp Brain Res       Date:  2018-08-21       Impact factor: 1.972

5.  Exogenous BDNF enhances the integration of chronically injured axons that regenerate through a peripheral nerve grafted into a chondroitinase-treated spinal cord injury site.

Authors:  Veronica J Tom; Harra R Sandrow-Feinberg; Kassi Miller; Cheryl Domitrovich; Julien Bouyer; Victoria Zhukareva; Michelle C Klaw; Michel A Lemay; John D Houlé
Journal:  Exp Neurol       Date:  2012-09-27       Impact factor: 5.330

6.  Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury.

Authors:  Brian K Kwon; Jie Liu; Corrie Messerer; Nao R Kobayashi; John McGraw; Loren Oschipok; Wolfram Tetzlaff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

7.  NG2+ progenitors derived from embryonic stem cells penetrate glial scar and promote axonal outgrowth into white matter after spinal cord injury.

Authors:  Sudhakar Vadivelu; Todd J Stewart; Yun Qu; Kevin Horn; Su Liu; Qun Li; Jerry Silver; John W McDonald
Journal:  Stem Cells Transl Med       Date:  2015-02-23       Impact factor: 6.940

8.  Neural progenitor cells grown on hydrogel surfaces respond to the product of the transgene of encapsulated genetically engineered fibroblasts.

Authors:  Mihir S Shanbhag; Justin D Lathia; Mohamed R Mughal; Nicola L Francis; Nicholas Pashos; Mark P Mattson; Margaret A Wheatley
Journal:  Biomacromolecules       Date:  2010-10-13       Impact factor: 6.988

9.  Motor axonal regeneration after partial and complete spinal cord transection.

Authors:  Paul Lu; Armin Blesch; Lori Graham; Yaozhi Wang; Ramsey Samara; Karla Banos; Verena Haringer; Leif Havton; Nina Weishaupt; David Bennett; Karim Fouad; Mark H Tuszynski
Journal:  J Neurosci       Date:  2012-06-13       Impact factor: 6.167

10.  Combined intrinsic and extrinsic neuronal mechanisms facilitate bridging axonal regeneration one year after spinal cord injury.

Authors:  Ken Kadoya; Shingo Tsukada; Paul Lu; Giovanni Coppola; Dan Geschwind; Marie T Filbin; Armin Blesch; Mark H Tuszynski
Journal:  Neuron       Date:  2009-10-29       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.